Skip to content

Preventive effects of esketamine on nausea and vomiting induced by carboprost tromethamine in caesarean

Preventive effects of esketamine on nausea and vomiting induced by carboprost tromethamine in caesarean

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100049983
Enrollment
Unknown
Registered
2021-08-15
Start date
2021-08-12
Completion date
Unknown
Last updated
2022-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

nausea and vomiting

Interventions

E Group:esketamine i.v after umbilical cord ligation
C Group:normal saline i.v after umbilical cord ligation

Sponsors

The First Affiliated Hospital of Zhengzhou University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: Full-term cesarean section with risk factors of uterine weakness (prolonged labor, scarred uterus, Placenta previa, macrosomia, multiple pregnancy, etc.), aged 20-40 years, body mass index (BMI) <30 Kg /m2,ASA I-II, signed informed consent for anesthesia.

Exclusion criteria

Exclusion criteria: Patients with consciousness disorder conbbined severe mental or nervous system diseases. Severe cardiovascular system diseases,evere liver and kidney disease, clotting abnormalities, history of allergies to ropivacaine and esketamine,The use of butanetriol is contraindicated.

Design outcomes

Primary

MeasureTime frame
the incidence and level of nausea;the incidence and level of vomiting;

Secondary

MeasureTime frame
Non-invasive blood systolic pressure/Non-invasive blood diastole pressure;heart rate;oxyhemoglobin saturation;respiratory depression;RAMSAY Sedation Score;

Countries

China

Contacts

Public ContactWang Tenghuan

The First Affiliated Hospital of Zhengzhou University

wth1422@163.com+86 18239938856

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026